 system chemotherapi urotheli cancer patient ureter obstruct aim studi toxic system chemotherapi respons rate patient ureter obstruct urotheli cancer studi group patient cisplatin methotrex upper tract dilat drainag nephrostomi normal upper tract respons rate patient measur primari metastat diseas signific differ group group normal group biochem measur renal function cours chemotherapi seriou haematolog toxic cycl group cycl normal group complet respons rate dilat group normal group increas chemotherapi toxic patient upper tract dilat signific complet respons rate patient upper tract dilat renal impair